Dr. James Callaway, PhD
Senior Vice President and Head of Immunotherapy AD Clinical Programs
Industry: Healthcare
Overview
Dr. Callaway was appointed senior vice president, head of immunotherapy Alzheimer's disease clinical programs, in March 2004. Since joining Elan in 1995, Dr. Callaway has held several senior positions, including interim head of global development and vice president of biopharmaceutical development services. Prior to joining Elan, he worked at Bayer Pharmaceuticals. Dr. Callaway received his PhD in biological chemistry from University of California, Los Angeles, and a Bachelor of Science in chemistry from California State University, Chico.
Did anyone at Microsoft ever watch the (gasp!) offensively funny show Family Guy?
Ex-Morgan Stanley exec Zoe Cruz is now heading her own hedge fund. Are Wall Street's leaders done?
Martha, Bernie and Skilling know that what you wear for court can go a long way in public perception.
Health Care
